Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2009 1
2010 2
2011 3
2012 1
2013 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Merkel Cell Carcinoma: New Trends.
Zwijnenburg EM, Lubeek SFK, Werner JEM, Amir AL, Weijs WLJ, Takes RP, Pegge SAH, van Herpen CML, Adema GJ, Kaanders JHAM. Zwijnenburg EM, et al. Among authors: amir al. Cancers (Basel). 2021 Mar 31;13(7):1614. doi: 10.3390/cancers13071614. Cancers (Basel). 2021. PMID: 33807446 Free PMC article. Review.
Allo-HLA reactivity of virus-specific memory T cells is common.
Amir AL, D'Orsogna LJ, Roelen DL, van Loenen MM, Hagedoorn RS, de Boer R, van der Hoorn MA, Kester MG, Doxiadis II, Falkenburg JH, Claas FH, Heemskerk MH. Amir AL, et al. Blood. 2010 Apr 15;115(15):3146-57. doi: 10.1182/blood-2009-07-234906. Epub 2010 Feb 16. Blood. 2010. PMID: 20160165 Free article.
Mixed T cell receptor dimers harbor potentially harmful neoreactivity.
van Loenen MM, de Boer R, Amir AL, Hagedoorn RS, Volbeda GL, Willemze R, van Rood JJ, Falkenburg JH, Heemskerk MH. van Loenen MM, et al. Among authors: amir al. Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10972-7. doi: 10.1073/pnas.1005802107. Epub 2010 Jun 1. Proc Natl Acad Sci U S A. 2010. PMID: 20534461 Free PMC article.
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer.
Amir AL, van der Steen DM, van Loenen MM, Hagedoorn RS, de Boer R, Kester MD, de Ru AH, Lugthart GJ, van Kooten C, Hiemstra PS, Jedema I, Griffioen M, van Veelen PA, Falkenburg JH, Heemskerk MH. Amir AL, et al. Clin Cancer Res. 2011 Sep 1;17(17):5615-25. doi: 10.1158/1078-0432.CCR-11-1066. Epub 2011 Jul 19. Clin Cancer Res. 2011. PMID: 21771875 Free article.
Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease.
Amir AL, Hagedoorn RS, van Luxemburg-Heijs SA, Marijt EW, Kruisselbrink AB, Frederik Falkenburg JH, Heemskerk MH. Amir AL, et al. Biol Blood Marrow Transplant. 2012 Feb;18(2):210-9. doi: 10.1016/j.bbmt.2011.10.018. Epub 2011 Oct 19. Biol Blood Marrow Transplant. 2012. PMID: 22015995 Free article. Clinical Trial.